Regulations.gov document
Attachment 1 Approved labeling for the RLD, Excedrin (migraine) re Citizen Petition from…
Supporting & Related Material · FDA-2016-P-1213 · posted May 2, 2016
Key facts
| Document ID | FDA-2016-P-1213-0003 |
|---|---|
| Title | Attachment 1 Approved labeling for the RLD, Excedrin (migraine) re Citizen Petition from Medtech Products Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-P-1213 |
| Posted | May 2, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: